The clinical study for effectiveness and safeness of levetiracetam combination therapy for symptomatic seizure
Phase 3
- Conditions
- symptomatic intractable epilepsy
- Registration Number
- JPRN-UMIN000006186
- Lead Sponsor
- Yamanashi Univiersity
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
The pateints which can not be estimated the attack frequency during study peroid and with serious liver dysfunction, renal dysfunaction, severe brain vascular disease, brain tumor or metal disfunction. A women with pregnacy or a possibility of pregnacy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method disppearace rate of attack reduction rate of attack frequency
- Secondary Outcome Measures
Name Time Method QOLIE-31